Rationale and design of a phase 3b, prospective, randomized, open label, blinded-endpoint, multicenter trial of the efficacy and safety of urokinase thrombolysis comparing with antiplatelet agents for patients with minor stroke.
Lu ZhaoChenyang JiangYongli TaoYuan GaoYafang XuRui ZhangKai LiuHong-Qiu GuYilong WangYu-Ming XuBo SongPublished in: International journal of stroke : official journal of the International Stroke Society (2021)
TRUST trial may potentially provide promising and affordable thrombolysis for acute minor ischemic stroke in the developing parts of the world.
Keyphrases
- phase iii
- open label
- phase ii
- study protocol
- double blind
- placebo controlled
- clinical trial
- pulmonary embolism
- atrial fibrillation
- acute ischemic stroke
- phase ii study
- randomized controlled trial
- liver failure
- respiratory failure
- drug induced
- squamous cell carcinoma
- radiation therapy
- health information
- extracorporeal membrane oxygenation
- social media